These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10350022)

  • 1. Preparation and characterization of carmustine loaded polyanhydride wafers for treating brain tumors.
    Domb AJ; Israel ZH; Elmalak O; Teomim D; Bentolila A
    Pharm Res; 1999 May; 16(5):762-5. PubMed ID: 10350022
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.
    Domb AJ; Rock M; Perkin C; Yipchuck G; Broxup B; Villemure JG
    Biomaterials; 1995 Sep; 16(14):1069-72. PubMed ID: 8519927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of convective flow in carmustine delivery to a brain tumor.
    Arifin DY; Lee KY; Wang CH; Smith KA
    Pharm Res; 2009 Oct; 26(10):2289-302. PubMed ID: 19639394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of polyanhydride for local BCNU delivery carriers.
    Kim MS; Seo KS; Seong HS; Cho SH; Lee HB; Hong KD; Kim SK; Khang G
    Biomed Mater Eng; 2005; 15(3):229-38. PubMed ID: 15912003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
    Nagpal S
    Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral edema associated with Gliadel wafers: two case studies.
    Weber EL; Goebel EA
    Neuro Oncol; 2005 Jan; 7(1):84-9. PubMed ID: 15701285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of polyanhydrides for drug delivery applications.
    Tamada J; Langer R
    J Biomater Sci Polym Ed; 1992; 3(4):315-53. PubMed ID: 1350734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results for Treatment of Newly-Diagnosed Glioblastoma Using Carmustine Wafers(Gliadel
    Kumabe T; Shibahara I; Saito R
    No Shinkei Geka; 2018 May; 46(5):367-376. PubMed ID: 29794312
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at first diagnosis.
    Salvati M; D'elia A; Frati A; Brogna C; Santoro A; Delfini R
    J Neurosurg Sci; 2011 Mar; 55(1):1-6. PubMed ID: 21464805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy.
    Dang W; Daviau T; Brem H
    Pharm Res; 1996 May; 13(5):683-91. PubMed ID: 8860422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
    Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
    J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-friendly bioerodible drug delivery systems.
    Heller J
    J Control Release; 2009 Jan; 133(2):88-9. PubMed ID: 18930773
    [No Abstract]   [Full Text] [Related]  

  • 14. [What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].
    Ducray F; Honnorat J
    Presse Med; 2007 Sep; 36(9 Pt 2):1249-54. PubMed ID: 17350791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the carmustine implant.
    Fleming AB; Saltzman WM
    Clin Pharmacokinet; 2002; 41(6):403-19. PubMed ID: 12074689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
    Wu MP; Tamada JA; Brem H; Langer R
    J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the NICE Technology Appraisal 121 (gliadel and temozolomide) on survival in high-grade glioma.
    Barr JG; Grundy PL
    Br J Neurosurg; 2012 Dec; 26(6):818-22. PubMed ID: 22715955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary biodistribution and cellular uptake of intranasally administered monodisperse particles.
    Brenza TM; Petersen LK; Zhang Y; Huntimer LM; Ramer-Tait AE; Hostetter JM; Wannemuehler MJ; Narasimhan B
    Pharm Res; 2015 Apr; 32(4):1368-82. PubMed ID: 25297714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable polymers for drug delivery to the brain.
    Langer R
    ASAIO Trans; 1988; 34(4):945-6. PubMed ID: 2851308
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.